Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Brief report: a pilot open clinical trial of intravenous immunoglobulin in childhood autism.

Literature DB >> 10382136

Brief report: a pilot open clinical trial of intravenous immunoglobulin in childhood autism.

G DelGiudice-Asch¹, L Simon, J Schmeidler, C Cunningham-Rundles, E Hollander.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 1999 PMID： 10382136 DOI： 10.1023/a:1023096728131

Source DB: PubMed Journal: J Autism Dev Disord ISSN： 0162-3257

× No keyword cloud information.

21 in total

1. Demonstration of inter- and intraspecies differences in serotonin binding sites by antibodies from an autistic child.

Authors: R D Todd; R D Ciaranello
Journal: Proc Natl Acad Sci U S A Date: 1985-01 Impact factor: 11.205

2. Possible association of the extended MHC haplotype B44-SC30-DR4 with autism.

Authors: R P Warren; V K Singh; P Cole; J D Odell; C B Pingree; W L Warren; C W DeWitt; M McCullough
Journal: Immunogenetics Date: 1992 Impact factor: 2.846

3. Increased frequency of the null allele at the complement C4b locus in autism.

Authors: R P Warren; V K Singh; P Cole; J D Odell; C B Pingree; W L Warren; E White
Journal: Clin Exp Immunol Date: 1991-03 Impact factor: 4.330

4. Deficiency of suppressor-inducer (CD4+CD45RA+) T cells in autism.

Authors: R P Warren; L J Yonk; R A Burger; P Cole; J D Odell; W L Warren; E White; V K Singh
Journal: Immunol Invest Date: 1990-06 Impact factor: 3.657

5. Antibodies to myelin basic protein in children with autistic behavior.

Authors: V K Singh; R P Warren; J D Odell; W L Warren; P Cole
Journal: Brain Behav Immun Date: 1993-03 Impact factor: 7.217

6. Changes of soluble interleukin-2, interleukin-2 receptor, T8 antigen, and interleukin-1 in the serum of autistic children.

Authors: V K Singh; R P Warren; J D Odell; P Cole
Journal: Clin Immunol Immunopathol Date: 1991-12

Review 7. Immunoglobulin treatment in epilepsy, a review of the literature.

Authors: B G van Engelen; W O Renier; C M Weemaes; F J Gabreels; H Meinardi
Journal: Epilepsy Res Date: 1994-12 Impact factor: 3.045

8. Anti-GM1 antibodies in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) treated with intravenous immunoglobulin (IVIg).

Authors: I N van Schaik; M Vermeulen; P A van Doorn; A Brand
Journal: J Neuroimmunol Date: 1994-10 Impact factor: 3.478

Review 9. Autoimmunity in autism.

Authors: Amanda M Enstrom; Judy A Van de Water; Paul Ashwood
Journal: Curr Opin Investig Drugs Date: 2009-05

Review 10. The Use of Complementary Alternative Medicine in Children and Adolescents with Autism Spectrum Disorder.

Authors: Melissa DeFilippis
Journal: Psychopharmacol Bull Date: 2018-01-15

Brief report: a pilot open clinical trial of intravenous immunoglobulin in childhood autism.

1. Demonstration of inter- and intraspecies differences in serotonin binding sites by antibodies from an autistic child.

2. Possible association of the extended MHC haplotype B44-SC30-DR4 with autism.

3. Increased frequency of the null allele at the complement C4b locus in autism.

4. Deficiency of suppressor-inducer (CD4+CD45RA+) T cells in autism.

5. Antibodies to myelin basic protein in children with autistic behavior.

6. Changes of soluble interleukin-2, interleukin-2 receptor, T8 antigen, and interleukin-1 in the serum of autistic children.

Review 7. Immunoglobulin treatment in epilepsy, a review of the literature.

8. Anti-GM1 antibodies in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) treated with intravenous immunoglobulin (IVIg).

9. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability.

10. Immune abnormalities in patients with autism.

Review 1. The pathophysiology and treatment of autism.

2. Regarding secretin for treating autistic disorder.

Review 3. Beyond the brain: A multi-system inflammatory subtype of autism spectrum disorder.

4. Treatment of Autism Spectrum Disorder in Children and Adolescents.

5. Pharmacotherapy of target symptoms in autistic spectrum disorders.

Review 6. Immune Abnormalities in Autism Spectrum Disorder-Could They Hold Promise for Causative Treatment?

Review 7. Impact of Immunoglobulin Therapy in Pediatric Disease: a Review of Immune Mechanisms.

8. Adaptive and Innate Immune Responses in Autism: Rationale for Therapeutic Use of Intravenous Immunoglobulin.

Review 9. Autoimmunity in autism.

Review 10. The Use of Complementary Alternative Medicine in Children and Adolescents with Autism Spectrum Disorder.